Literature DB >> 16055946

Second-generation antipsychotic drugs, olanzapine, quetiapine, and clozapine enhance neurite outgrowth in PC12 cells via PI3K/AKT, ERK, and pertussis toxin-sensitive pathways.

Xiao-Hong Lu1, Donard S Dwyer.   

Abstract

Second-generation antipsychotic drugs, olanzapine, quetiapine, and clozapine, were found to enhance neurite outgrowth induced by nerve growth factor (NGF) in PC12 cells. These drugs increased the number of cells bearing neurites, the length of primary neurites, and the size of the cell body of NGF-differentiated PC12 cells. In addition, the drugs induced sprouting of neurite-like processes in PC12 cells in the absence of NGF. Olanzapine, quetiapine, and clozapine enhanced the phosphorylation of Akt and ERK in combination with NGF, and specific inhibitors of these pathways attenuated these effects. Pretreatment of cells overnight with pertussis toxin had no effect on NGF-induced differentiation but significantly decreased the effects of the antipsychotic drugs on neurite outgrowth, suggesting that Gi/Go-coupled receptors are involved in the response to drug. A better understanding of the mechanisms underlying the effects of the second-generation drugs might suggest new therapeutic targets for enhancement of neurite outgrowth.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16055946     DOI: 10.1385/jmn:27:1:043

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  33 in total

1.  Stimulation by antipsychotic agents of mitogen-activated protein kinase (MAPK) coupled to cloned, human (h)serotonin (5-HT)(1A) receptors.

Authors:  Didier Cussac; Delphine Duqueyroix; Adrian Newman-Tancredi; Mark J Millan
Journal:  Psychopharmacology (Berl)       Date:  2002-04-30       Impact factor: 4.530

2.  The phosphatidylinositol-3 kinase (PI3K)-Akt pathway suppresses neurite branch formation in NGF-treated PC12 cells.

Authors:  Maiko Higuchi; Keisuke Onishi; Norihisa Masuyama; Yukiko Gotoh
Journal:  Genes Cells       Date:  2003-08       Impact factor: 1.891

3.  Evidence that antipsychotic drugs are inverse agonists at D2 dopamine receptors.

Authors:  D A Hall; P G Strange
Journal:  Br J Pharmacol       Date:  1997-06       Impact factor: 8.739

Review 4.  Regulation of mitogen-activated protein kinase signaling networks by G protein-coupled receptors.

Authors:  J S Gutkind
Journal:  Sci STKE       Date:  2000-07-11

Review 5.  Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.

Authors:  Gary L Johnson; Razvan Lapadat
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

6.  NS-417, a novel compound with neurotrophic-like effects.

Authors:  Lone Dagø; Dan Peters; Morten Meyer; Barbara Hartz; Vibeke Kruse; Jørgen Drejer; Mette Grønborg
Journal:  Neurochem Res       Date:  2002-02       Impact factor: 3.996

7.  Regulation of neuronal survival by the serine-threonine protein kinase Akt.

Authors:  H Dudek; S R Datta; T F Franke; M J Birnbaum; R Yao; G M Cooper; R A Segal; D R Kaplan; M E Greenberg
Journal:  Science       Date:  1997-01-31       Impact factor: 47.728

8.  Cytotoxicity of conventional and atypical antipsychotic drugs in relation to glucose metabolism.

Authors:  Donard S Dwyer; Xiao-Hong Lu; Ronald J Bradley
Journal:  Brain Res       Date:  2003-05-02       Impact factor: 3.252

9.  Protective effects of atypical antipsychotic drugs on PC12 cells after serum withdrawal.

Authors:  Ou Bai; Zelan Wei; Wenfu Lu; Rudy Bowen; David Keegan; Xin-Min Li
Journal:  J Neurosci Res       Date:  2002-07-15       Impact factor: 4.164

10.  NS 1231, a novel compound with neurotrophic-like effects in vitro and in vivo.

Authors:  Lone Dagø; Christian Bonde; Dan Peters; Arne Møller; Signe Farsø Bomholt; J Barbara P Hartz; Morten Meyer; Jørgen Drejer; Mette Grønborg
Journal:  J Neurochem       Date:  2002-04       Impact factor: 5.372

View more
  32 in total

Review 1.  Inhibition of Akt with small molecules and biologics: historical perspective and current status of the patent landscape.

Authors:  Margrith E Mattmann; Sydney L Stoops; Craig W Lindsley
Journal:  Expert Opin Ther Pat       Date:  2011-06-02       Impact factor: 6.674

2.  Antipsychotic drugs activate the C. elegans akt pathway via the DAF-2 insulin/IGF-1 receptor.

Authors:  Kathrine R Weeks; Donard S Dwyer; Eric J Aamodt
Journal:  ACS Chem Neurosci       Date:  2010-03-25       Impact factor: 4.418

Review 3.  Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection.

Authors:  Jeffrey A Lieberman; Frank P Bymaster; Herbert Y Meltzer; Ariel Y Deutch; Gary E Duncan; Christine E Marx; June R Aprille; Donard S Dwyer; Xin-Min Li; Sahebarao P Mahadik; Ronald S Duman; Joseph H Porter; Josephine S Modica-Napolitano; Samuel S Newton; John G Csernansky
Journal:  Pharmacol Rev       Date:  2008-09       Impact factor: 25.468

4.  Antibodies directed to Neisseria gonorrhoeae impair nerve growth factor-dependent neurite outgrowth in Rat PC12 cells.

Authors:  B Reuss
Journal:  J Mol Neurosci       Date:  2013-11-08       Impact factor: 3.444

Review 5.  Antipsychotic drug mechanisms: links between therapeutic effects, metabolic side effects and the insulin signaling pathway.

Authors:  R R Girgis; J A Javitch; J A Lieberman
Journal:  Mol Psychiatry       Date:  2008-04-15       Impact factor: 15.992

6.  Psychotropic Medications and Their Effect on Brain Volumes in Childhood Psychopathology.

Authors:  Natasha Marrus; Marisa Bell; Joan L Luby
Journal:  Child Adolesc Psychopharmacol News       Date:  2014-04

7.  The activation of the Akt/PKB signalling pathway in the brains of clozapine-exposed rats is linked to hyperinsulinemia and not a direct drug effect.

Authors:  G C Smith; H McEwen; J D Steinberg; P R Shepherd
Journal:  Psychopharmacology (Berl)       Date:  2014-05-07       Impact factor: 4.530

8.  Serotonin 5-HT(7) receptor blockade reverses behavioral abnormalities in PACAP-deficient mice and receptor activation promotes neurite extension in primary embryonic hippocampal neurons: therapeutic implications for psychiatric disorders.

Authors:  Minako Tajiri; Atsuko Hayata-Takano; Kaoru Seiriki; Katsuya Ogata; Keisuke Hazama; Norihito Shintani; Akemichi Baba; Hitoshi Hashimoto
Journal:  J Mol Neurosci       Date:  2012-07-29       Impact factor: 3.444

9.  Dysregulation of the norepinephrine transporter sustains cortical hypodopaminergia and schizophrenia-like behaviors in neuronal rictor null mice.

Authors:  Michael A Siuta; Sabrina D Robertson; Heidi Kocalis; Christine Saunders; Paul J Gresch; Vivek Khatri; Chiyo Shiota; J Philip Kennedy; Craig W Lindsley; Lynette C Daws; Daniel B Polley; Jeremy Veenstra-Vanderweele; Gregg D Stanwood; Mark A Magnuson; Kevin D Niswender; Aurelio Galli
Journal:  PLoS Biol       Date:  2010-06-08       Impact factor: 8.029

Review 10.  The neurotrophic and neuroprotective effects of psychotropic agents.

Authors:  Joshua Hunsberger; Daniel R Austin; Ioline D Henter; Guang Chen
Journal:  Dialogues Clin Neurosci       Date:  2009       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.